PADMAJAMAHESHBABU

CADILAHC INVERSE HEAD AND SHOULDER

PADMAJAMAHESHBABU 已更新   
NSE:CADILAHC   None


Cadila nod for clinical trials of Covid-19 vaccine.
The company has completed pre clinical development and plans to begin the trials in July 2020.

BEARISH ENGULFING FORMED IN HOURLY CHART.

TRADE ACCORDING TO YOUR ANALYSIS.
評論:
TRADE ACHIEVED THE TARGET................
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。